The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Reducing The Growing Burden Of Cardiovascular Disease In The Developing World
Open accessAbstract
Cardiovascular disease (CVD) has become the number-one cause of death in the developing world. This epidemic has the potential to place a large social and economic burden on developing countries, where CVD tends to strike those in their prime working years. Since resources for managing CVD are limited, it is important that interventions be guided by cost-effectiveness results for low- and middle-income countries. Despite the burden, cost-effective strategies exist at the population and individual levels for reducing CVD. Integral to all personal intervention strategies is an adequate assessment of the underlying risk of disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Epidemiologic Transition: A Theory of the Epidemiology of Population Change
OMRAN, A. R. (2005) · The Milbank Quarterly · doi:10.1111/j.1468-0009.2005.00398.x · Cited by 3,823
Disease control priorities in developing countries
(2006) · Choice Reviews Online · doi:10.5860/choice.44-0343 · Cited by 3,628
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Yusuf, S., Reddy, S., Ôunpuu, S., & Anand, S. (2001) · Circulation · doi:10.1161/hc4601.099487 · Cited by 2,972
Global Burden of Disease and Risk Factors
(2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,605
A strategy to reduce cardiovascular disease by more than 80%
Wald, N. J., & Law, M. R. (2003) · BMJ · doi:10.1136/bmj.326.7404.1419 · Cited by 1,568
Peto, R. (2000) · BMJ · doi:10.1136/bmj.321.7257.323 · Cited by 1,409
Williams, B., Poulter, N. R., Brown, M. J., Davis, M., McInnes, G. T., Potter, J. F., Sever, P. S., & McG Thom, S. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001683 · Cited by 1,272
Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis
Lindholm, L. H., Carlberg, B., & Samuelsson, O. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67573-3 · Cited by 999
The Fourth Stage of the Epidemiologic Transition: The Age of Delayed Degenerative Diseases
Olshansky, S. J., & Ault, A. B. (1986) · The Milbank Quarterly · doi:10.2307/3350025 · Cited by 820
Cited by
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., Luchsinger, J. A., Ogunniyi, A., Perry, E. K., Potocnik, F., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70169-8 · Cited by 1,233
Laslett, L. J., Alagona, P., Clark, B. A., Drozda, J. P., Saldivar, F., Wilson, S. R., Poe, C., & Hart, M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.002 · Cited by 768
Hypertension in developing countries
Ibrahim, M. M., & Damasceno, A. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60861-7 · Cited by 731
Chitosan as biomaterial in drug delivery and tissue engineering
Ahsan, S. M., Thomas, M., Reddy, K. K., Sooraparaju, S. G., Asthana, A., & Bhatnagar, I. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.08.140 · Cited by 684
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
Précoma, D. B., Oliveira, G. M. M. D., Simão, A. F., Dutra, O. P., Coelho-Filho, O. R., Izar, M. C. D. O., Póvoa, R. M. D. S., Giuliano, I. D. C. B., Alencar Filho, A. C. D., Machado, C. A., et al. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190204 · Cited by 434
Global Variation in the Relative Burden of Stroke and Ischemic Heart Disease
Kim, A. S., & Johnston, S. C. (2011) · Circulation · doi:10.1161/circulationaha.111.018820 · Cited by 386
Rasella, D., Harhay, M. O., Pamponet, M. L., Aquino, R., & Barreto, M. L. (2014) · BMJ · doi:10.1136/bmj.g4014 · Cited by 355
Emerging chitin and chitosan nanofibrous materials for biomedical applications
Ding, F., Deng, H., Du, Y., Shi, X., & Wang, Q. (2014) · Nanoscale · doi:10.1039/c4nr02814g · Cited by 342
Statins for the primary prevention of cardiovascular disease
Taylor, F., Ward, K., Moore, T. H., Burke, M., Davey Smith, G., Casas, J. P., & Ebrahim, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub4 · Cited by 305
Slopen, N., Koenen, K. C., & Kubzansky, L. D. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.11.003 · Cited by 151
The Cardiovascular Research Network: A New Paradigm for Cardiovascular Quality and Outcomes Research
Go, A. S., Magid, D. J., Wells, B., Sung, S. H., Cassidy-Bushrow, A. E., Greenlee, R. T., Langer, R. D., Lieu, T. A., Margolis, K. L., Masoudi, F. A., et al. (2008) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.801654 · Cited by 137
AbuMweis, S., Jew, S., Tayyem, R., & Agraib, L. (2018) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12493 · Cited by 122
Mao, Y., Lin, W., Wen, J., & Chen, G. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001225 · Cited by 108
Chan, C. V., & Kaufman, D. R. (2010) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2009.09.006 · Cited by 56
Beratarrechea, A., Diez-Canseco, F., Fernández, A., Kanter, R., Letona, P., Martinez, H., Miranda, J. J., Ramirez-Zea, M., & Rubinstein, A. (2015) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2015.322.1611 · Cited by 13
Metadata
- Authors
- Gaziano, T. A.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2007-01
- Volume
- 26
- Issue
- 1
- Pages
- 13-24
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W2141018154
- Cited by
- 304
- References
- 28
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.